Prevalence of Sjögren syndrome among Nagasaki atomic bomb survivors

Annals of the Rheumatic Diseases

Volumn 67, Issue 5, 2008, Pages 689-695

  Hida, A ^a   Akahoshi, M ^a   Takagi, Y ^b   Ashizawa, K ^a   Imaizumi, M ^a   Soda, M ^a   Maeda, R ^a   Nakashima, E ^a   Ida, H ^b   Kawakami, A ^b   Nakamura, T ^b   Eguchi, K ^b  

^a RADIATION EFFECTS RESEARCH FOUNDATION   (Japan)

^b NAGASAKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

LA ANTIBODY; RO ANTIBODY; AUTOANTIBODY; AUTOANTIGEN; RIBONUCLEOPROTEIN; SS A ANTIGEN; SS B ANTIGEN; SS-A ANTIGEN; SS-B ANTIGEN;

ADULT; AGED; ARTICLE; ATOMIC BOMB; CONTROLLED STUDY; ECHOGRAPHY; FEMALE; HUMAN; HYPOSALIVATION; IONIZING RADIATION; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUESTIONNAIRE; RADIATION DOSE; SALIVATION; SCHIRMER TEST; SJOEGREN SYNDROME; SURVIVOR; TEAR FLOW; XEROPHTHALMIA; XEROSTOMIA; ATOMIC WARFARE; IMMUNOLOGY; JAPAN; MIDDLE AGED; PREVALENCE; RADIATION EXPOSURE; SALIVARY GLAND;

AGED; AGED, 80 AND OVER; AUTOANTIBODIES; AUTOANTIGENS; FEMALE; HUMANS; JAPAN; MALE; MIDDLE AGED; NUCLEAR WARFARE; PREVALENCE; RADIATION DOSAGE; RIBONUCLEOPROTEINS; SALIVARY GLANDS; SJOGREN'S SYNDROME; SURVIVORS; XEROPHTHALMIA; XEROSTOMIA;

EID: 42449138690     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2007.073650     Document Type: Article

References (31)

1. Jacobsson LT, Axell TE, Hansen BU, Henricsson VJ, Larsson A, Lieberkind K, et al. Dry eyes or mouth - an epidemiological study in Swedish adults, with special reference to primary Sjögren's syndrome. J Autoimmun 1989;2:521-7.
2. Drosos AA, Andonopoulos AP, Costopoulos JS, Papadimitriou CS, Moutsopoulos HM. Prevalence of primary Sjögren's syndrome in an elderly population. Br J Rheumatol 1988;27:123-7.
3. Dafni UG, Tzioufas AG, Staikos P, Skopouli FN, Moutsopoulos HM. Prevalence of Sjögren's syndrome in a closed rural community. Ann Rheum Dis 1997;56:521-5.
4. Thomas E, Hay EM, Hajeer A, Silman AJ. Sjögren's syndrome: a community-based study of prevalence and impact. Br J Rheumatol 1998;37:1069-76.
5. Strickland RW, Tesar JT, Berne BH, Hobbs BR, Lewis DM, Welton RC. The frequency of sicca syndrome in an elderly female population. J Rheumatol 1987;14:766-71.
6. Bjerrum KB. Keratoconjunctivitis sicca and primary Sjögren's syndrome in a Danish population aged 30-60 years. Acta Ophthalmol Scand 1997;75:281-6.
7. Fujibayashi T, Sugai S, Miyasaka N, Hayashi Y, Tsubota K. Revised Japanese criteria for Sjögren's syndrome (1999): availability and validity. Mod Rheumatol 2004;14:425-34.
8. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554-8.
9. Fujiwara S, Carter RL, Akiyama M, Akahoshi M, Kodama K, Shimaoka K, et al. Autoantibodies and immunoglobulins among atomic bomb survivors. Radiat Res 1994;137:89-95.
10. Nagataki S, Shibata Y, Inoue S, Yokoyama N, Izumi M, Shimaoka K. Thyroid diseases among atomic bomb survivors in Nagasaki. JAMA 1994;272:364-70.
11. Imaizumi M, Usa T, Tominaga T, Neriishi K, Akahoshi M, Nakashima E, et al. Radiation dose-response relationships for thyroid nodules and autoimmune thyroid diseases in Hiroshima and Nagasaki atomic bomb survivors 55-58 years after radiation exposure. JAMA 2006;295:1011-22.
12. Atomic Bomb Casualty Commission. Research plan for joint ABCC-NIH adult health study in Hiroshima and Nagasaki, Japan. ABCC Technical Report 1962:11-62.
13. Kohler PF, Winter ME. A quantitative test for xerostomia. The Saxon test, an oral equivalent of the Schirmer test. Arthritis Rheum 1985;28:1128-32.
14. van Bijsterveld OP. Diagnostic tests in the Sicca syndrome. Arch Ophthalmol 1969;82:10-14.
15. Takagi Y, Sumi M, Sumi T, Ichikawa Y, Nakamura T. MR microscopy of the parotid glands in patients with Sjögren's syndrome: quantitative MR diagnostic criteria. Am J Neuroradiol 2005;26:1207-14.
16. Ariji Y, Ohki M, Eguchi K, Izumi M, Ariji E, Mizokami A, et al. Texture analysis of sonographic features of the parotid gland in Sjögren's syndrome. Am J Roentgenol 1996;166:935-41.
17. Izumi M, Eguchi K, Ohki M, Uetani M, Hayashi K, Kita M, et al. MR imaging of the parotid gland in Sjögren's syndrome: a proposal for new diagnostic criteria. Am J Roentgenol 1996;166:1483-7.
18. Izumi M, Eguchi K, Nakamura H, Nagataki S, Nakamura T. Premature fat deposition in the salivary glands associated with Sjögren's syndrome: MR and CT evidence. Am J Neuroradiol 1997;18:951-8.
19. Young R, Kerr G, eds. Reassessment of the atomic bomb radiation dosimetry for Hiroshima and Nagasaki - dosimetry system 2002. Hiroshima, Japan: Radiation Effects Research Foundation, 2005.
20. Pierce DA, Stram DO, Vaeth M. Allowing for random errors in radiation dose estimates for the atomic bomb survivor data. Radiat Res 1990;123:275-84.
21. Akaike H. Information theory and an extension of the maximum likelihood principle. In: Petrov B, Czaki F, eds. Second international symposium on information theory. Budapest: Akademiai Kiado, 1973:267-81.
22. Preston D, Lubin J, Pierce DA, McConney M. Epicure software package. Seattle, Washington, USA: Hirosoft International Corp, 1993.
23. Zhang NZ, Shi CS, Yao QP, Pan GX, Wang LL, Wen ZX, et al. Prevalence of primary Sjögren's syndrome in China. J Rheumatol 1995;22:659-61.
24. Alamanos Y, Tsifetaki N, Voulgari PV, Venetsanopoulou Ai, Siozos C, Drosos AA. Epidemiology of primary Sjögren's syndrome in north-west Greece, 1982-2003. Rheumatology (Oxford) 2006;45:187-91.
25. Tomsic M, Logar D, Grmek M, Perkovic T, Kveder T. Prevalence of Sjögren's syndrome in Slovenia. Rheumatology (Oxford) 1999;38:164-70.
26. Xavier RM, Yamauchi Y, Nakamura M, Tanigawa Y, Ishikura H, Tsunematsu T, et al. Antinuclear antibodies in healthy aging people: a prospective study. Mech Age Dev 1995;78:145-54.
27. Eisbruch A, Ten Haken RK, Kim HM, Marsh LH, Ship JA. Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer. Int J Radiat Oncol Biol Phys 1999;45:577-87.
28. Bussels B, Maes A, Flamen P, Lambin P, Erven K, Hermans R, et al. Dose-response relationships within the parotid gland after radiotherapy for head and neck cancer. Radiother Oncol 2004;73:297-306.
29. Land CE, Saku T, Hayashi Y, Takahara O, Matsuura H, Tokuoka S, et al. Incidence of salivary gland tumors among atomic bomb survivors, 1950-1987. Evaluation of radiation-related risk. Radiat Res 1996;146:28-36.
30. Saku T, Hayashi Y, Takahara O, Matsuura H, Tokunaga M, Tokunaga M, et al. Salivary gland tumors among atomic bomb survivors, 1950-1987. Cancer 1997;79:1465-75.
31. Hay EM, Thomas E, Pal B, Hajeer A, Chambers H, Silman AJ. Weak association between subjective symptoms or and objective testing for dry eyes and dry mouth: results from a population based study. Ann Rheum Dis 1998;57:20-4.